首頁 › 前列腺癌 › 俄亥俄州 › Cincinnati
Cincinnati, OH 的 前列腺癌 臨床試驗
18 項針對 前列腺癌 的研究正在 Cincinnati（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- 還有 3 項
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Saint Elizabeth Healthcare Edgewood, Edgewood · 距離 8 英里
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- TriState Urologic Services PSC Inc. dba The Urology Group, Cincinnati
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- Oncology Hematology Care Incorporated, Cincinnati
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Urology Group - Solaris Network, Cincinnati
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- Oncology Hematology Care Incorporated, Cincinnati
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
招募中2 期
- Solaris Health - The Urology Group, Cincinnati
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- Oncology Hematology Care Incorporated, Cincinnati
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- University of Cincinnati Medical Center, Cincinnati
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 還有 1 項
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
招募中觀察性研究
- The University of Cinncinatti, Cincinnati
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 還有 1 項
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
招募中3 期
- Oncology Hematology Care Inc-Kenwood, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 113, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Cincinnati
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距離 15 英里
Real World Prostate Cancer Registry
招募中觀察性研究
- Cincinnati Cancer Advisors, Cincinnati
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Cincinnati 的其他研究
- 非小細胞肺癌35 項研究
- 癌症（所有類型）27 項研究
- 乳癌25 項研究
- 心臟衰竭24 項研究
- 大腸直腸癌21 項研究
- 急性髓系白血病20 項研究
- 轉移性癌症20 項研究
- 卵巢癌19 項研究
- 肺癌19 項研究
- 肥胖症19 項研究
- 多發性骨髓瘤17 項研究
- 黑色素瘤17 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。